Clinical phenotype and genotype analysis of 24 epileptic children with KCNQ2 gene variation
Journal Title: Journal of Clinical Pediatrics - Year 2025, Vol 43, Issue 2
Abstract
[Objective] To investigate the clinical and genetic characteristics of children with epilepsy caused by variations of the KCNQ2 gene (OMIM #602235). [Methods] The clinical data of 24 children with KCNQ2 gene variants (NM_172107) detected by whole-exome sequencing (WES) from October 2018 to November 2022 were analyzed, and the genotypic characteristics and treatment were analyzed. [Results] A total of 24 children (14 boys and 10 girls) with epilepsy caused by KCNQ2 gene variations were included. The age of the first seizure in these children ranged from 17 hours after birth to 5 years old. Among them, 16 children (66.7%) were younger than 6 months. According to the clinical prognosis, there were 1 case of benign familial neonatal epilepsy (BFNE), 6 cases of benign familial infantile epilepsy (BFIE), 4 cases of self-limited epilepsy syndrome that could not be classified, and 13 cases of KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE). The main genetic variation was missense mutation (62.5%), and 7 new KCNQ2 mutation sites were found. Among them, c.1411C>T was evaluated as pathogenic, c.602G>C, c.1031G>A, c.2159_2173del (p.720_725delinsR) was evaluated as likely pathogenic. The median follow-up time of the 24 patients was 40 months. 13 patients had varying degrees of developmental delay in KCNQ2-DEE, and the remaining 11 patients had good overall prognosis and normal cognitive development. [Conclusions] The age of seizures associated with KCNQ2 variation is mainly distributed in the neonatal period and early infancy. The prognosis of KCNQ2-DEE is poor. It is recommended that genetic testing should be performed as early as possible for the diagnosis of unexplained seizures in infancy.
Authors and Affiliations
Lihui WANG, Liping CUI, Huafang YANG, Lan LIU, Xiaona TANG, Qing ZHAO, Xin WANG, Baoguang LI
Keywords
Related Articles
- EP ID EP763256
- DOI 10.12372/jcp.2025.23e1140
- Views 17
- Downloads 0
Progress of intravenous thrombolysis in pediatric acute ischemic stroke
Pediatric acute ischemic stroke is a rare condition with a poor prognosis and significant recurrence rates. Intravenous tissue plasminogen activator (IV-TPA) has been proven to be an effective treatment for acute ischemi...
Security analysis of dinutuximab β in the treatment of pediatric neuroblastoma
[Objective ] To investigate the clinical response and security of dinutuximab β immunotherapy in neuroblastoma children. [Methods ] A retrospective analysis was performed on 13 children who received dinutuximab β immunot...
Examination of peripheral blood MDSCs quantitative variations and biological properties in infants with necrotizing enterocolitis: utilizing GEO database insights
[Objective] To investigate the correlation between peripheral blood myeloid-derived suppressor cells (MDSCs) levels and the severity of necrotizing enterocolitis (NEC), and the biological characteristics of MDSCs in NEC...
Expert consensus on family care for Duchenne muscular dystrophy (non-ambulatory stage)
Duchenne muscular dystrophy (DMD) is a severe X-linked recessive neuromuscular disorder characterized by progressive muscle weakness and eventual fatality. In recent years, more and more gene therapies have emerged, and...
Progress in pediatric autoimmune epilepsy
The field of autoimmune epilepsy has progressed tremendously in recent decades with the discovery of a wide range of neuronal antibodies and the increasing understanding of the pathogenesis of various immune-mediated syn...